Term ends Dec 9, 2030 · High confidence
20-year base term ends Dec 9, 2030
Dec 9, 2010
Dec 9, 2030
Sep 24, 2024
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 0 of 1 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 9, 2010, when application PCT/US2010/059719, the earliest non-provisional in its chain, was filed (this one was filed Sep 1, 2023) | Dec 9, 2030 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,129,823, US 11,197,821, US 11,786,518, US 9,814,701) | resolves to Dec 9, 2030, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 1 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Dec 9, 2030 | High confidence |
This family
| Application PCT/US2010/059719 | PCT application no patent term | no patent term |
| US 9,814,701 | In force Jul 2033 | Jul 2033 |
| Application 15/782,470 | Abandoned not computed | not computed |
| US 12,097,188 | this patent Dec 2030 | Dec 2030 |
| Application 18/786,975 | Pending not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 30, 2023 Reel 65396, frame 259 | Jordan, Thomas A.; Chabala, John Clifford; Cagle, Gerald D. | Neuron Systems, Inc. | Assignment of Assignor's Interest |
| Oct 30, 2023 Reel 65396, frame 271 | Neuron Systems, Inc. | Aldexa Therapeutics, Inc. | Change of Name |
| Oct 30, 2023 Reel 65396, frame 331 | Aldexa Therapeutics, Inc. | Aldeyra Therapeutics, Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 11,129,823, US 11,197,821, US 11,786,518, US 9,814,701, ends no earlier than this term, so it caps nothing.